Anxiety and Symptom Burden in Hemodialysis Patients
- Conditions
- ESRDAnxiety
- Registration Number
- NCT04143100
- Lead Sponsor
- The Rogosin Institute
- Brief Summary
Anxiety has been identified as a prevalent and significant co-morbid condition in patients with End Stage Renal Disease (ESRD) being treated with hemodialysis. In particular, anxious sensitivity to symptoms commonly experienced by dialysis patients may lead patients to prematurely terminate their dialysis sessions and may have consequences on their dialysis adequacy and overall quality of life.
The proposed study will examine the relationships between anxiety, depression, quality of life, symptom burden and dialysis prescription adherence. The primary regression analyses will be used to predict the influence of anxiety and depression (independently and together) on measures of adherence behaviors.
- Detailed Description
Additional analyses will examine the relationship of elevated anxiety and depression scores on symptom burden, QOL, and other measures of dialysis adherence. Retrospective data of the preceding three months will be used to calculate measures of dialysis adherence (shortening and skipping) and clinical parameters.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Receiving In-center hemodialysis
- Non-English speaking
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Generalized Anxiety Disorder-7 (GAD-7) This is a cross-sectional study, with anxiety scores being correlated with previous 6 months of adherence data Anxiety measure - higher scores indicate more anxiety
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The Rogosin Institute
🇺🇸New York, New York, United States